Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Neoplasms of the CNS

  Free Subscription

Articles published in J Nucl Med

Retrieve available abstracts of 36 articles:
HTML format

Single Articles

    January 2021
  1. JIMENEZ-FRANCO LD, Glatting G, Prasad V, Weber WA, et al
    Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in (177)Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.
    J Nucl Med. 2021;62:92-98.
    PubMed     Abstract available

    November 2020
  2. CECCON G, Lohmann P, Werner JM, Tscherpel C, et al
    Early treatment response assessment using (18)F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.
    J Nucl Med. 2020 Nov 6. pii: jnumed.120.254243. doi: 10.2967/jnumed.120.254243.
    PubMed     Abstract available

    September 2020
  3. GALLDIKS N, Abdulla DS, Scheffler M, Wolpert F, et al
    Treatment Monitoring of Immunotherapy and Targeted Therapy using (18)F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences.
    J Nucl Med. 2020 Sep 4. pii: jnumed.120.248278. doi: 10.2967/jnumed.120.248278.
    PubMed     Abstract available

    August 2020
  4. MIRIAN C, Duun-Henriksen AK, Maier AD, Pedersen MM, et al
    Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: an individual patient data meta-analysis.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.249607. doi: 10.2967/jnumed.120.249607.
    PubMed     Abstract available

  5. FILSS CP, Stegmayr C, Lohmann P, Galldiks N, et al
    Reply to: Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.251819. doi: 10.2967/jnumed.120.251819.

    July 2020
  6. NABAVIZADEH SA, Nasrallah IM, Pryma DA
    Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.251116. doi: 10.2967/jnumed.120.251116.

  7. TATEKAWA H, Hagiwara A, Yao J, Oughourlian TC, et al
    Voxel-Wise and Patient-Wise Correlation of (18)F-FDOPA PET, rCBV, and ADC in Treatment-Naive Diffuse Gliomas with Different Molecular Subtypes.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.247411. doi: 10.2967/jnumed.120.247411.
    PubMed     Abstract available

    May 2020
  8. KRAMER K, Donzelli M, Nwora E, Pandit-Taskar N, et al
    Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy.
    J Nucl Med. 2020;61:662-664.
    PubMed     Abstract available

    April 2020
  9. HERHAUS P, Lipkova J, Lammer F, Yakushev I, et al
    CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma.
    J Nucl Med. 2020 Apr 24. pii: jnumed.120.241703. doi: 10.2967/jnumed.120.241703.
    PubMed     Abstract available

    January 2020
  10. FILSS CP, Schmitz AK, Stoffels G, Stegmayr C, et al
    Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.238568. doi: 10.2967/jnumed.119.238568.
    PubMed     Abstract available

    September 2019
  11. DE ZWART PL, van Dijken BR, Holtman GA, Stormezand GN, et al
    Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.
    J Nucl Med. 2019 Sep 20. pii: jnumed.119.233809. doi: 10.2967/jnumed.119.233809.
    PubMed     Abstract available

  12. MAURER GD, Brucker DP, Stoffels G, Filipski K, et al
    (18)F-FET PET imaging in differentiating glioma progression from treatment-related changes - a single-center experience.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.234757. doi: 10.2967/jnumed.119.234757.
    PubMed     Abstract available

    March 2019
  13. GEISLER S, Stegmayr C, Niemietz N, Lohmann P, et al
    Treatment-related uptake of O-(2-[(18)F]fluoroethyl)-L-tyrosine and L-[methyl-(3)H]-methionine after tumor resection in rat glioma models.
    J Nucl Med. 2019 Mar 8. pii: jnumed.119.225680. doi: 10.2967/jnumed.119.225680.
    PubMed     Abstract available

    January 2019
  14. MARNER L, Nysom K, Sehested A, Borgwardt L, et al
    Early Postoperative (18)F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.220293. doi: 10.2967/jnumed.118.220293.
    PubMed     Abstract available

    December 2018
  15. FAHEY FH, Christian PE, Zukotynski K, Sexton-Stallone B, et al
    Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network.
    J Nucl Med. 2018 Dec 7. pii: jnumed.118.219998. doi: 10.2967/jnumed.118.219998.
    PubMed     Abstract available

    August 2018
  16. TINKLE C, Duncan E, Doubrovin M, Han Y, et al
    Evaluation of (11)C-methionine PET and anatomic MRI associations in diffuse intrinsic pontine glioma.
    J Nucl Med. 2018 Aug 2. pii: jnumed.118.212514. doi: 10.2967/jnumed.118.212514.
    PubMed     Abstract available

    March 2018
  17. JANNETTI SA, Carlucci G, Carney B, Kossatz S, et al
    PARP1-Targeted Radiotherapy in Mouse Models of Glioblastoma.
    J Nucl Med. 2018 Mar 23. pii: jnumed.117.205054. doi: 10.2967/jnumed.117.205054.
    PubMed     Abstract available

    December 2017
  18. OYEN WJG, Jones C
    ImmunoPET in pontine glioma : more than meets the eye ?
    J Nucl Med. 2017 Dec 7. pii: jnumed.117.200527. doi: 10.2967/jnumed.117.200527.

    November 2017
  19. PAPP L, Poetsch N, Grahovac M, Schmidbauer V, et al
    Glioma survival prediction with the combined analysis of in vivo 11C-MET-PET, ex vivo and patient features by supervised machine learning.
    J Nucl Med. 2017 Nov 24. pii: jnumed.117.202267. doi: 10.2967/jnumed.117.202267.
    PubMed     Abstract available

    August 2017
  20. MAULER J, Maudsley AA, Langen KJ, Nikoubashman O, et al
    Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: a hybrid PET-MRI study.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.196709. doi: 10.2967/jnumed.117.196709.
    PubMed     Abstract available

  21. VELDHUIJZEN VAN ZANTEN SEM, Sewing ACP, van Lingen A, Hoekstra OS, et al
    Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma.
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.197897. doi: 10.2967/jnumed.117.197897.
    PubMed     Abstract available

  22. WANG H, Hou B, Lu L, Feng M, et al
    PET/MR imaging in the diagnosis of hormone-producing pituitary micro-adenoma: a prospective pilot study.
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.191916. doi: 10.2967/jnumed.117.191916.
    PubMed     Abstract available

  23. RICHARD MA, Fouquet JP, Lebel R, Lepage M, et al
    Determination of an Optimal Pharmacokinetic Model of 18F-FET for Quantitative Applications in Rat Brain Tumors.
    J Nucl Med. 2017;58:1278-1284.
    PubMed     Abstract available

    June 2017
  24. FERREIRA DA PONTE K, Berro DH, Collet S, Constans JM, et al
    In vivo relationship between hypoxia and angiogenesis in human glioblastoma: a multimodal imaging study.
    J Nucl Med. 2017 Jun 8. pii: jnumed.116.188557. doi: 10.2967/jnumed.116.188557.
    PubMed     Abstract available

    May 2017
  25. SEGTNAN EA, Grupe P, Jarden JO, Gerke O, et al
    Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis.
    J Nucl Med. 2017;58:768-773.
    PubMed     Abstract available

    April 2017
  26. KUNZ WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, et al
    Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET-CT Compared to Contrast-Enhanced MRI.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.191932. doi: 10.2967/jnumed.117.191932.
    PubMed     Abstract available

    MRI and PET: noninvasive tools to probe diffuse intrinsic pontine glioma biology.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192526. doi: 10.2967/jnumed.117.192526.

    March 2017
  28. ZUKOTYNSKI K, Vajapeyam S, Fahey FH, Kocak M, et al
    Correlation of 18F-FDG PET and MR Apparent Diffusion Coefficient (ADC) Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.185389. doi: 10.2967/jnumed.116.185389.
    PubMed     Abstract available

  29. RAUSCH I, Rischka L, Ladefoged CN, Furtner J, et al
    PET/MRI for oncological brain imaging: A comparison of standard MR-based attenuation corrections with a novel, model-based approach for the Siemens mMR PET/MR system.
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.186148. doi: 10.2967/jnumed.116.186148.
    PubMed     Abstract available

    February 2017
  30. STEGMAYR C, Oliveira D, Niemietz N, Willuweit A, et al
    Influence of bevacizumab on blood-brain barrier permeability and O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.
    J Nucl Med. 2017 Feb 2. pii: jnumed.116.187047. doi: 10.2967/jnumed.116.187047.
    PubMed     Abstract available

    November 2016
  31. WONG FC
    Brain Tumor Imaging.
    J Nucl Med. 2016 Nov 17. pii: jnumed.116.186957.

    October 2016
  32. MICHELHAUGH SK, Muzik O, Guastella AR, Klinger NV, et al
    Assessment of tryptophan uptake and kinetics using 1-(2-[18F]fluoroethyl)-L-tryptophan and alpha-[11C]-methyl-L-tryptophan PET imaging in mice implanted with patient-derived brain tumor xenografts.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.179994.
    PubMed     Abstract available

  33. JANSEN M, Veldhuijzen van Zanten SE, Van Vuurden DG, Huisman M, et al
    Molecular Drug Imaging: 89Zr-bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.180216.
    PubMed     Abstract available

  34. UNTERRAINER M, Galldiks N, Suchorska B, Kowalew LC, et al
    18F-FET PET uptake characteristics in patients with newly diagnosed and untreated brain metastasis.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.180075.
    PubMed     Abstract available

    September 2016
  35. LODGE MA, Holdhoff M, Leal JP, Bag AK, et al
    Repeatability of 18F-FLT PET in a Multi-Center Study of Patients with High Grade Glioma.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.178434.
    PubMed     Abstract available

    March 2016
  36. SEKINE T, Burgos N, Warnock G, Huellner MW, et al
    Multi atlas-based attenuation correction for brain FDG-PET imaging using a TOF-PET/MR scanner- comparison with clinical single atlas- and CT-based attenuation correction.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.169045.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.